| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |